SPNing our wheels-Pancreatic solid pseudopapillary neoplasm as an extraluminal etiology of persistent duodenal

Kanak V Kennedy1,2, Jibraan A Fawad1, Y Dana Neugut1

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.

JPGN Reports
|May 19, 2025
PubMed

Insights

Pediatric duodenal ulcers causing upper GI bleeding can stem from rare pancreatic tumors. This case highlights solid pseudopapillary neoplasms (SPNs) as an unusual extrinsic cause, emphasizing the need for suspicion with recurrent ulceration.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Oncology
  • Gastrointestinal Pathology

Background:

  • Pediatric upper gastrointestinal (GI) bleeding from duodenal ulceration is a critical condition.
  • A wide range of diagnoses can cause these ulcers.
  • Pancreatic tumors are an uncommon cause of duodenal pathology.

Purpose of the Study:

  • To report a rare case of pediatric duodenal ulceration caused by a pancreatic head solid pseudopapillary neoplasm (SPN).
  • To emphasize SPNs as an extrinsic cause of duodenal ulceration.
  • To increase awareness of extraluminal etiologies for recurrent duodenal ulcers.

Main Methods:

  • Case report presentation.
  • Review of clinical presentation, diagnostic workup, and management.
  • Literature review on pancreatic SPNs and duodenal pathology.

Main Results:

  • A pediatric patient presented with recurrent upper GI bleeding due to duodenal ulceration.
  • The ulceration was found to be caused by a solid pseudopapillary neoplasm (SPN) of the pancreatic head.
  • The SPN was identified as an extrinsic mass compressing the duodenum.

Conclusions:

  • Pancreatic SPNs are a rare but significant extrinsic cause of duodenal ulceration in children.
  • Recurrent or progressive duodenal ulceration without obvious internal causes warrants investigation for extraluminal masses.
  • Early recognition and diagnosis of pancreatic SPNs are crucial for effective management in pediatric patients.

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
111
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
56
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
72
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
183
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
327
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
55